SCHEMBL13899227

SCHEMBL13899227

CC[C@H]1O[C@@H](C)[C@@H](C)C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21214912 1.00 — —
SCHEMBL19263829 1.00 — —
SCHEMBL10260288 1.00 — —
SCHEMBL10260241 1.00 — —
SCHEMBL12300420 1.00 — —
SCHEMBL19263831 1.00 — —
SCHEMBL12746267 1.00 — —
SCHEMBL35361 1.00 — —
SCHEMBL15298329 0.97 — —
SCHEMBL13026644 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858956-B2 6-aza-nucleoside prodrugs as antiviral agents for treating virus infections SOUTHERN RESEARCH INSTITUTE (US) 2024-01-02 — — US disclosed
US-7501504-B2 Detectable labeled nucleoside analogs and methods of use thereof ROCHE MOLECULAR SYSTEMS, INC. (US) 2009-03-10 — — US disclosed
US-7456266-B2 Detectable labeled nucleoside analogs and methods of use thereof ROCHE MOLECULAR SYSTEMS, INC. (US) 2008-11-25 — — US disclosed
US-7452674-B1 Detectable labeled nucleoside analogs and methods of use thereof ROCHE MOLECULAR SYSTEMS, INC. (US) 2008-11-18 — — US disclosed
US-20070208169-A1 DETECTABLE LABELED NUCLEOSIDE ANALOGS AND METHODS OF USE THEREOF ROCHE MOLECULAR SYSTEMS, INC. (US) 2007-09-06 — — US disclosed
US-20070202576-A1 DETECTABLE LABELED NUCLEOSIDE ANALOGS AND METHODS OF USE THEREOF ROCHE MOLECULAR SYSTEMS, INC. (US) 2007-08-30 — — US disclosed
Send feedback